Skip to main content
PMC home page
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 1994 Sep;20(3):146–151. doi: 10.1136/jme.20.3.146

First trimester prenatal diagnosis: earlier is not necessarily better.

J A Boss 1
PMCID: PMC1376499  PMID: 7996559

Abstract

In the past few years considerable attention has been given to a relatively new method of prenatal diagnosis known as chorionic villus sampling (CVS). Because CVS can be performed in the first trimester it is hailed by many as a significant advance over amniocentesis. What has not been as publicized, however, are the disadvantages of CVS and earlier prenatal diagnosis. The emotional costs of CVS in terms of the greater number of both spontaneous and selective abortions following CVS, the use of CVS for sex selection and, because of the greater social acceptability of first trimester abortion, the possibility of increased pressure on women to undergo prenatal diagnosis by health insurance companies, medical professionals and government agencies, all need to be weighed against the advantages of early prenatal diagnosis.

Full text

PDF
151

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergman B., Claesson U., Mark J. Risk evaluation in a small series of transabdominal chorionic villus sampling. Gynecol Obstet Invest. 1991;31(4):189–191. doi: 10.1159/000293155. [DOI] [PubMed] [Google Scholar]
  2. Blumberg B. D., Golbus M. S., Hanson K. H. The psychological sequelae of abortion performed for a genetic indication. Am J Obstet Gynecol. 1975 Aug 1;122(7):799–808. doi: 10.1016/0002-9378(75)90718-8. [DOI] [PubMed] [Google Scholar]
  3. Boué J., Bou A, Lazar P. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology. 1975 Aug;12(1):11–26. doi: 10.1002/tera.1420120103. [DOI] [PubMed] [Google Scholar]
  4. Burton B. K., Schulz C. J., Burd L. I. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol. 1992 May;79(5 ):726–730. [PubMed] [Google Scholar]
  5. Evans M. I., Drugan A., Koppitch F. C., 3rd, Zador I. E., Sacks A. J., Sokol R. J. Genetic diagnosis in the first trimester: the norm for the 1990s. Am J Obstet Gynecol. 1989 Jun;160(6):1332–1339. doi: 10.1016/0002-9378(89)90852-1. [DOI] [PubMed] [Google Scholar]
  6. Ferguson-Smith M. A. Early prenatal diagnosis. Prenat Diagn. 1991 Aug;11(8):489–491. doi: 10.1002/pd.1970110802. [DOI] [PubMed] [Google Scholar]
  7. Firth H. V., Boyd P. A., Chamberlain P., MacKenzie I. Z., Lindenbaum R. H., Huson S. M. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet. 1991 Mar 30;337(8744):762–763. doi: 10.1016/0140-6736(91)91374-4. [DOI] [PubMed] [Google Scholar]
  8. Fletcher J. C. Ethics and trends in applied human genetics. Birth Defects Orig Artic Ser. 1983;19(5):143–158. [PubMed] [Google Scholar]
  9. Furlong R. M., Black R. B. Pregnancy termination for genetic indications: the impact on families. Soc Work Health Care. 1984 Fall;10(1):17–34. doi: 10.1300/J010v10n01_02. [DOI] [PubMed] [Google Scholar]
  10. Golbus M. S., Loughman W. D., Epstein C. J., Halbasch G., Stephens J. D., Hall B. D. Prenatal genetic diagnosis in 3000 amniocenteses. N Engl J Med. 1979 Jan 25;300(4):157–163. doi: 10.1056/NEJM197901253000402. [DOI] [PubMed] [Google Scholar]
  11. Gostin L. Genetic discrimination: the use of genetically based diagnostic and prognostic tests by employers and insurers. Am J Law Med. 1991;17(1-2):109–144. [PubMed] [Google Scholar]
  12. Grannum P. A., Copel J. A. Invasive fetal procedures. Radiol Clin North Am. 1990 Jan;28(1):217–226. [PubMed] [Google Scholar]
  13. Green J. M. Prenatal screening and diagnosis: some psychological and social issues. Br J Obstet Gynaecol. 1990 Dec;97(12):1074–1076. doi: 10.1111/j.1471-0528.1990.tb02492.x. [DOI] [PubMed] [Google Scholar]
  14. Heckerling P. S., Verp M. S. Genetic risk and early versus late prenatal testing. Lancet. 1991 Feb 9;337(8737):363–363. doi: 10.1016/0140-6736(91)90990-7. [DOI] [PubMed] [Google Scholar]
  15. Johnson A., Cowchock F. S., Darby M., Wapner R., Jackson L. G. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies. Prenat Diagn. 1991 Jul;11(7):443–450. doi: 10.1002/pd.1970110706. [DOI] [PubMed] [Google Scholar]
  16. Johnson A., Wapner R. J., Davis G. H., Jackson L. G. Mosaicism in chorionic villus sampling: an association with poor perinatal outcome. Obstet Gynecol. 1990 Apr;75(4):573–577. [PubMed] [Google Scholar]
  17. Kaplan P., Normandin J., Jr, Wilson G. N., Plauchu H., Lippman A., Vekemans M. Malformations and minor anomalies in children whose mothers had prenatal diagnosis: comparison between CVS and amniocentesis. Am J Med Genet. 1990 Nov;37(3):366–370. doi: 10.1002/ajmg.1320370315. [DOI] [PubMed] [Google Scholar]
  18. Lippman A. Prenatal genetic testing and screening: constructing needs and reinforcing inequities. Am J Law Med. 1991;17(1-2):15–50. [PubMed] [Google Scholar]
  19. Mancini G., Perona M., Dall'Amico D., Bollati C., Albano F., Mazzone R., Rosso M., Carbonara A. O. Screening for fetal Down's syndrome with maternal serum markers--an experience in Italy. Prenat Diagn. 1991 Apr;11(4):245–252. doi: 10.1002/pd.1970110406. [DOI] [PubMed] [Google Scholar]
  20. Meade T. W., Grant A. M. Chorionic villus sampling. BMJ. 1992 Jan 18;304(6820):185–186. doi: 10.1136/bmj.304.6820.185-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Miny P., Hammer P., Gerlach B., Tercanli S., Horst J., Holzgreve W., Eiben B. Mosaicism and accuracy of prenatal cytogenetic diagnoses after chorionic villus sampling and placental biopsies. Prenat Diagn. 1991 Aug;11(8):581–589. doi: 10.1002/pd.1970110815. [DOI] [PubMed] [Google Scholar]
  22. Rhoads G. G., Jackson L. G., Schlesselman S. E., de la Cruz F. F., Desnick R. J., Golbus M. S., Ledbetter D. H., Lubs H. A., Mahoney M. J., Pergament E. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med. 1989 Mar 9;320(10):609–617. doi: 10.1056/NEJM198903093201001. [DOI] [PubMed] [Google Scholar]
  23. Simpson J. L. Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosis. Am J Med Genet. 1990 Feb;35(2):165–173. doi: 10.1002/ajmg.1320350205. [DOI] [PubMed] [Google Scholar]
  24. Smidt-Jensen S., Philip J. Comparison of transabdominal and transcervical CVS and amniocentesis: sampling success and risk. Prenat Diagn. 1991 Aug;11(8):529–537. doi: 10.1002/pd.1970110808. [DOI] [PubMed] [Google Scholar]
  25. Tymstra T. J., Bajema C., Beekhuis J. R., Mantingh A. Women's opinions on the offer and use of prenatal diagnosis. Prenat Diagn. 1991 Dec;11(12):893–898. doi: 10.1002/pd.1970111203. [DOI] [PubMed] [Google Scholar]
  26. Verp M. S., Bombard A. T., Simpson J. L., Elias S. Parental decision following prenatal diagnosis of fetal chromosome abnormality. Am J Med Genet. 1988 Mar;29(3):613–622. doi: 10.1002/ajmg.1320290320. [DOI] [PubMed] [Google Scholar]
  27. White-van Mourik M. C., Connor J. M., Ferguson-Smith M. A. The psychosocial sequelae of a second-trimester termination of pregnancy for fetal abnormality. Prenat Diagn. 1992 Mar;12(3):189–204. doi: 10.1002/pd.1970120308. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES